Metabolic surgery in treatment of obese Japanese patients with type 2 diabetes: a joint consensus statement from the Japanese Society for Treatment of Obesity, the Japan Diabetes Society, and the Japan Society for the Study of Obesity
| العنوان: | Metabolic surgery in treatment of obese Japanese patients with type 2 diabetes: a joint consensus statement from the Japanese Society for Treatment of Obesity, the Japan Diabetes Society, and the Japan Society for the Study of Obesity |
|---|---|
| المؤلفون: | Wataru Ogawa, Nobuya Inagaki, Michio Shimabukuro, K Ueki, Nobuhiro Shojima, Motoyoshi Tsujino, Junji Fujikura, Hiroaki Masuzaki, Eri Kikkawa, Koutaro Yokote, Satoshi Ugi, Hitoshi Nishizawa, Atsuhito Saiki, Takehiro Nozaki, Hiroaki Watada, Karin Hayashi, Yushi Hirota, Iichiro Shimomura, Yasushi Ishigaki, Akira Sasaki, Hidenori Koyama, Ichiro Tatsuno, Yosuke Seki, Takashi Kadowaki, Takeshi Naitoh, Masayuki Ohta, Toshimasa Yamauchi, Takashi Yamaguchi, Shinichi Okazumi, Kazunori Kasama, Takeshi Miyatsuka |
| المصدر: | Diabetology international |
| بيانات النشر: | Springer Singapore, 2021. |
| سنة النشر: | 2021 |
| مصطلحات موضوعية: | Bariatric surgery, Sleeve gastrectomy, medicine.medical_specialty, business.industry, Statement (logic), Endocrinology, Diabetes and Metabolism, medicine.medical_treatment, Metabolic surgery, Diabetes, Report of the Committee, Type 2 diabetes, Duodenojejunal bypass, medicine.disease, Obesity, Scientific evidence, Family medicine, Diabetes mellitus, Internal Medicine, medicine, business, Beneficial effects |
| الوصف: | Bariatric surgery has been shown to have a variety of metabolically beneficial effects for patients with type 2 diabetes (T2D), and is now also called metabolic surgery. At the 2nd Diabetes Surgery Summit held in 2015 in London, the indication for bariatric and metabolic surgery was included in the “algorithm for patients with type T2D”. With this background, the Japanese Society for Treatment of Obesity (JSTO), the Japan Diabetes Society (JDS) and the Japan Society for the Study of Obesity (JASSO) have formed a joint committee to develop a consensus statement regarding bariatric and metabolic surgery for the treatment of Japanese patients with T2D. Eventually, the consensus statement was announced at the joint meeting of the 38th Annual Meeting of JSTO and the 41st Annual Meeting of JASSO convened in Toyama on March 21, 2021. In preparing the consensus statement, we used Japanese data as much as possible as scientific evidence to consider the indication criteria, and set two types of recommendation grades, “recommendation” and “consideration”, for items for which recommendations are possible. We hope that this statement will be helpful in providing evidence-based high-quality care through bariatric and metabolic surgery for the treatment of obese Japanese patients with T2D. Supplementary Information The online version contains supplementary material available at 10.1007/s13340-021-00551-0. |
| اللغة: | English |
| تدمد: | 2190-1686 2190-1678 |
| URL الوصول: | https://explore.openaire.eu/search/publication?articleId=doi_dedup___::144acfe26b1a78fb3121edd6f791bbca http://europepmc.org/articles/PMC8574153 |
| حقوق: | OPEN |
| رقم الأكسشن: | edsair.doi.dedup.....144acfe26b1a78fb3121edd6f791bbca |
| قاعدة البيانات: | OpenAIRE |
Find this article in full text from Springer Verlag. | تدمد: | 21901686 21901678 |
|---|